A tetracycline-responsive promoter system reveals the role of a secreted binding protein for FGFs during the early phase of tumor growth

Biochem Biophys Res Commun. 1996 Dec 24;229(3):930-7. doi: 10.1006/bbrc.1996.1904.

Abstract

We showed previously that a secreted binding protein for FGFs (BP) can induce tumor growth and angiogenesis of a non-tumorigenic human cell line (SW-13). To study the contribution of BP to different phases of tumor growth, we employed a regulated promoter system which is highly active in SW-13 cells and can be downregulated >20-fold by treatment with tetracycline. We demonstrate that expression of BP in SW-13 cells (SW-13/tetBP cells) induces colony formation in soft agar and tumor growth in athymic nude mice. Tetracycline downregulated BP expression in these cells and prevented their colony formation in soft agar. Continuous tetracycline treatment of animals suppressed BP expression in tumors grown from SW-13/tetBP cells and reduced growth of the xenografts. Initiation of tetracycline treatment after xenograft tumors had been established had no effect on further tumor expansion in spite of downregulated BP levels. These data suggest that BP expression plays a role mainly in the early stages of tumor progression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic / genetics*
  • Cells, Cultured
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Mice
  • Molecular Sequence Data
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Protein Synthesis Inhibitors / pharmacology*
  • Receptors, Fibroblast Growth Factor / genetics*
  • Receptors, Fibroblast Growth Factor / metabolism
  • Tetracycline / pharmacology*

Substances

  • Protein Synthesis Inhibitors
  • Receptors, Fibroblast Growth Factor
  • Tetracycline

Associated data

  • GENBANK/M60047